We also made the minimum required clinical model (sex/age), and we observed that it was not significant either and that it also distorts the ability of CK19 to predict OS and DFS in lung cancer patients (Supplementary Material Table S3 and Figure S1). This evidence concerns the gene KRT19 and lung cancer.